Highly Influential Citations6
Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
Abstract 758 Introduction: Chronic lymphocytic leukemia (CLL) is a disease of the elderly with over 70% of patients diagnosed over the age of 65. Age and comorbidity are considered when prescribing… Continue Reading
IMPORTANCE Little is known about patients' experiences of advanced basal cell carcinoma (aBCC) and basal cell carcinoma nevus syndrome (BCCNS), a rare genetic disorder that greatly increases the… Continue Reading
SummaryThe study objective was to quantify health care utilisation and medical costs for Medicare beneficiaries with atrial fibrillation (AF). Patients aged >65 years with an AF diagnosis were… Continue Reading
6583 Background: The addition of rituximab (RTX) to CVP (cyclophosphamide, vincristine, prednisone) in the treatment of advanced follicular lymphoma increases median time to progression by 17 month...
6616 Background: Although cancer remains a leading cause of death, the last few decades have seen improvements in the diagnosis and treatment of the disease. We measure the gains in cancer survival… Continue Reading
OBJECTIVE Inpatient conditions that might be avoided through improved outpatient services are called Ambulatory Care Sensitive Indicators, and they include pyelonephritis in nonpregnant adults. No… Continue Reading
Introduction: A disproportionate number of newly diagnosed acute myeloid leukemia (AML) occurs in elderly patients. Conventional chemotherapy treatments for AML may be highly toxic and elderly… Continue Reading
7052 Background: Obinutuzumab, also known as GA101 (G), is a novel therapy shown to have improved PFS in combination with chlorambucil (GClb) compared to rituximab + chlorambucil (RClb) in the recent… Continue Reading
9007 Background: Advances in mM have increased treatment (tx) options, where previously, few therapies were available. This study compares HC and adverse event (AE) costs in a U.S. managed care… Continue Reading
17531 Background: About 15,000 new cases of CLL are diagnosed annually in the United States but the direct medical costs attributable to CLL have not been delineated. Methods: We analyzed the CLL… Continue Reading